Dr. Sheri Prentiss from the Live Today Foundation talks about the debilitating disease of Lymphedema and methods of prevention for at-risk patients.

BioSpace was thrilled to host a virtual panel discussion to hear how workplaces can improve their D&I strategies and help organizations thrive. We heard insightful advice from panelists from Amgen, Intellia Therapeutics, Obsidian Therapeutics, Omega Therapeutics and Athira Pharma.

NeuroRx plans to file for emergency use authorization (EUA) for Zyesami after the drug has successfully demonstrated a 10-day accelerated recovery from respiratory failure patients that have critical COVID-19 and have been treated with high-flow nasal oxygen. “We look forward to reporting the final 60-day efficacy data shortly,” Dr. Jonathan Javitt, the NeuroRx CEO said […]